ONAPGO 4.9 mg/mL
Apomorphine hydrochloride · INJECTION, SOLUTION · MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
ONAPGO is a injection, solution containing apomorphine hydrochloride at 4.9 mg/mL, taken subcutaneous. Manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
Key Facts
- Brand Name
- ONAPGO
- Generic Name
- Apomorphine hydrochloride
- NDC Code (Product)
27505-006- Manufacturer
- MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
- Strength
- 4.9 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA214056
- Marketing Start
- 02/04/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ONAPGO used for?
ONAPGO contains Apomorphine hydrochloride. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is ONAPGO a controlled substance?
ONAPGO is not classified as a controlled substance by the DEA.
What is the generic name for ONAPGO?
The generic name for ONAPGO is Apomorphine hydrochloride. There are 2 other brand versions of Apomorphine hydrochloride.
What is the NDC code for ONAPGO 4.9 mg/mL?
The NDC (National Drug Code) for ONAPGO 4.9 mg/mL is 27505-006, listed by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.